Intelligent Bio Solutions has reported changes in its outstanding common stock count as of January 2, 2025. The update reflects two recent transactions: shares sold through an At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. dated September 18, 2024, and the issuance of 8,109 restricted common stock shares under an Investor Relations agreement with ClearThink Capital Partners LLC from February 29, 2024.Following these transactions, the company's total outstanding common stock stands at 4,807,068 shares as of the close of business on January 2, 2025.

Intelligent Bio Solutions has reported changes in its outstanding common stock count as of January 2, 2025. The update reflects two recent transactions: shares sold through an At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. dated September 18, 2024, and the issuance of 8,109 restricted common stock shares under an Investor Relations agreement with ClearThink Capital Partners LLC from February 29, 2024.Following these transactions, the company's total outstanding common stock stands at 4,807,068 shares as of the close of business on January 2, 2025.